Article

Bbarrons.com on 2022-04-05 16:16

Novartis CEO Continues His Shake-Up, Says It Will Save More Than $1 Billion Annually3 min read

The reorganization is the latest move from Vas Narasimhan, who took over the Swiss drugmaker in 2018.

Switzerland

Vas Narasimhan

Related news

BNovartis Will Cut Up to 8,000 Jobs Under CEO's Shake-Up Plan1 min read barrons.com
Switzerland
MNovartis hemoglobinuria trial meets two primary endpoints1 min read marketwatch.com
Basel , Switzerland
GSK buys out Novartis in $13 billion consumer healthcare shake-up timesofmalta.com
Switzerland , Germany , India , Europe
BNovartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash4 min read barrons.com
Switzerland
BNovartis Earnings Rise, Says Review of Sandoz Unit Progressing2 min read barrons.com
Switzerland
BThis Is What Wall Street Has Wrong About Novartis, Says CEO4 min read barrons.com
Wall Street
MNovartis sales and profit drop, but backs 2022 guidance1 min read marketwatch.com
Basel , Switzerland
BNovartis Stock Climbs. It's All About a Hike in Outlook and $15 Billion Share Buyback. 1 min read barrons.com
Switzerland
BNovartis Will Sell Back Its Roche Stake for $21 Billion. Both Stocks Are Rising.1 min read barrons.com
Switzerland
Novartis sells joint venture stake to GSK for $13 billion sanluisobispo.com
India , Switzerland
Novartis to buy The Medicines Company for $9.7 billion Merced Sun-Star
New Jersey , Switzerland
MNovartis prostate cancer drug trial meets primary endpoint1 min read marketwatch.com
Switzerland
US seeks $3.3 billion for Novartis 'kickbacks'thelocal.ch
Luterbach , Canton of Solothurn , French Open , Paris , Pacific Ocean
BOversold Novartis: Juicy Yield, $9 Billion Pipeline barrons.com
Switzerland
BNovartis to Spend Bulk of Roche Windfall on Buying Back Stock, Not M&A3 min read barrons.com
Windfall
Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: 'A Journey To Focus On Data And Digital'Forbes
Switzerland